Skip to main content

Share Article

Urenco announces Ad Louter as Director of Urenco Nederland

16 October 2014 Local News

Urenco Limited is pleased to announce the appointment of Mr Ad Louter as Director of Urenco Nederland B.V., effective from February 1, 2015.

Mr Louter will succeed Mr Huub Rakhorst as Managing Director on May 1, 2015, who is due to retire from his position on this date.

Mr Louter is a mechanical engineer from Delft University and is currently CEO of the Dutch utility N.V. EPZ. Previous to that, he held managerial positions with Jacobs and Stork in the Netherlands and abroad.

Share Article

Line

More local stories

Sharing expertise at the Waste Management Symposium

Local 15 March 2022

Colleagues from Urenco Nuclear Stewardship joined industry professionals at the Waste Management Symposium in Phoenix, Arizona.

Read more Sharing expertise at the Waste Management Symposium

Colleagues from Urenco Nuclear Stewardship joined industry professionals at the Waste Management Symposium in Phoenix, Arizona.

Read more Sharing expertise at the Waste Management Symposium

About Urenco

Urenco is an international supplier of enrichment services and fuel cycle products with sustainability at the core of its business. Operating in a pivotal area of the nuclear fuel supply chain for 50 years, Urenco facilitates zero carbon electricity generation for consumers around the world.

With its head office near London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Using centrifuge technology designed and developed by Urenco, and through the expertise of our people, the Urenco Group provides safe, cost effective and reliable services; operating within a framework of high environmental, social and governance standards, complementing international safeguards.

Urenco is committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.

Back to
the goals